Related Experiment Video

Updated: May 13, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

DNA demethylation and cancer metastasis: therapeutic implications

Moshe Szyf1

  • 1McGill University, Department of Pharmacology and Therapeutics, 3655 Sir William Osler Promenade, Montreal PQ, H3G 1Y6, Canada +1 514 398 7107 ; +1 514 398 6690 ; moshe.szyf@mcgill.ca.

Expert Opinion on Drug Discovery
|March 15, 2013
PubMed
Abstract

Insights

DNA methylation, a key gene regulator, shows contrasting patterns in cancer. While hypermethylation silences tumor suppressors, hypomethylation may activate prometastatic genes, suggesting new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • DNA methylation is a critical epigenetic mechanism regulating gene expression.
  • Aberrant DNA methylation patterns, including hypermethylation and hypomethylation, are hallmarks of cancer.
  • While hypermethylation of tumor suppressor genes is well-studied, the role of hypomethylation in cancer progression is increasingly recognized.

Purpose of the Study:

  • To highlight the emerging role of DNA hypomethylation in cancer.
  • To discuss the potential of targeting hypomethylation for cancer therapy.
  • To contrast the roles of hypermethylation and hypomethylation in oncogenesis.

Main Methods:

  • Literature review and synthesis of existing research on DNA methylation in cancer.
  • Analysis of the dual roles of DNA methylation (hyper- and hypomethylation) in gene regulation and cancer.
  • Discussion of pharmacological modulation of DNA methylation pathways.

Main Results:

  • DNA methylation patterns are significantly altered in cancer, with both hypermethylation and hypomethylation playing distinct roles.
  • Hypermethylation is associated with the silencing of tumor suppressor genes.
  • Hypomethylation may contribute to cancer progression by activating prometastatic genes.

Conclusions:

  • Both DNA methylation and demethylation are druggable targets.
  • Inhibiting DNA hypomethylation presents a promising new strategy for antimetastatic therapy.
  • Understanding the balance of DNA methylation is crucial for developing effective cancer treatments.

More Related Videos

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...